Cart
sales@molnova.com
Antiviral agent
CAS No. 380458-45-7
Antiviral agent( —— )
Catalog No. M36065 CAS No. 380458-45-7
Antiviral agent is thiazolidin-4-one with anti-hepatitis B activity
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 275 | In Stock |
|
| 5MG | 255 | In Stock |
|
| 10MG | 374 | In Stock |
|
| 25MG | 562 | In Stock |
|
| 50MG | 770 | In Stock |
|
| 100MG | 1051 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2102 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAntiviral agent
-
NoteResearch use only, not for human use.
-
Brief DescriptionAntiviral agent is thiazolidin-4-one with anti-hepatitis B activity
-
DescriptionAntiviral agent is thiazolidin-4-one with anti-hepatitis B activity
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHBV
-
RecptorHBV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number380458-45-7
-
Formula Weight399.53
-
Molecular FormulaC20H21N3O2S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(CCOC)N1C(C=2C(=NN(C2)C3=CC=CC=C3)C4=CC=CS4)SCC1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
ccc_R08
ccc_R08 is an orally available HBV cccDNA inhibitor that reduces extracellular levels of HBV DNA, HBsAg, and HBeAg in a dose-dependent manner. ccc_R08 is investigational for use in the treatment of HBV infections. ccc_R08 has been shown to be effective in the treatment of hepatitis C virus (HCV).
-
NTCP binder peptide ...
NTCP binder peptide WL4 is a macrocyclic peptide, pan-genotypic inhibitor of HBV cellular entry via targeting the cell-surface receptor for HBV.
-
Risedronate Sodium
Risedronate Sodium, a nitrogen-containing bisphosphonate, inhibits osteoclast-mediated bone resorption and modulates bone metabolism, used in the treatment of osteoporosis.
